Quick Answer
Alto Neuroscience, Inc. reported Earnings Per Share Diluted of $2.19 (loss) per share for the year ending 2025.
- Alto Neuroscience, Inc. showed an increase of +12.4% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Alto Neuroscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: $1.97 (loss) per share | Q2 2023: $2.33 (loss) per share | Q3 2023: $2.44 (loss) per share | Q1 2024: $0.76 (loss) per share | Q2 2024: $0.60 (loss) per share | Q3 2024: $0.62 (loss) per share | Q1 2025: $0.56 (loss) per share | Q2 2025: $0.65 (loss) per share | Q3 2025: $0.52 (loss) per share.
- Over the full 3 years of available data (2023 to 2025), Alto Neuroscience, Inc.'s Earnings Per Share Diluted has grown by 77.5%.
- Historical annual values: Fiscal year 2025: $2.19 (loss) per share | Fiscal year 2024: $2.50 (loss) per share | Fiscal year 2023: $9.73 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: